Insights

Strategic Partnerships Orphazyme has a history of forming strategic partnerships as seen with recent collaborations with KemPharm, Inc. Potential sales opportunities may arise from leveraging these partnerships to expand market reach and offer combined solutions to a broader customer base.

Global Expansion With expanding global presence across Denmark, Switzerland, and the US, Orphazyme is well-positioned to tap into diverse markets. Sales development representatives can explore new markets and capitalize on the company's reach to drive revenue growth.

Innovative Therapies Orphazyme's focus on innovative therapies for neurodegenerative orphan diseases presents a unique sales proposition. Sales professionals can highlight the company's pioneering treatments to attract healthcare providers and patients seeking advanced solutions.

Financial Stability Despite recent strategic shifts and leadership changes, Orphazyme's financial outlook and funding of $109M provide a solid foundation for sales initiatives. Understanding the financial health can instill confidence in potential clients and investors.

Competitive Positioning By analyzing similar companies in the biotechnology space, such as iTeos Therapeutics and AlloVir, sales representatives can identify competitive advantages and tailor sales strategies to differentiate Orphazyme's offerings in the market segment.

Similar companies to Orphazyme A/S

Orphazyme A/S Tech Stack

Orphazyme A/S uses 8 technology products and services including jQuery Migrate, Underscore.js, Webpack, and more. Explore Orphazyme A/S's tech stack below.

jQuery Migrate
Javascript Libraries
Underscore.js
Javascript Libraries
Webpack
Miscellaneous
Ubuntu
Operating Systems
Amazon Web Services
Platform As A Service
PHP
Programming Languages
Yoast SEO
Search Engines
Twitter
Widgets

Media & News

Orphazyme A/S's Email Address Formats

Orphazyme A/S uses at least 1 format(s):

Orphazyme A/S Email Formats	Example	Percentage
First.Last@orphazyme.com	John.Doe@orphazyme.com	45%
Last@orphazyme.com	Doe@orphazyme.com	5%
First.Last@orphazyme.com	John.Doe@orphazyme.com	45%
Last@orphazyme.com	Doe@orphazyme.com	5%

Frequently Asked Questions

Where is Orphazyme A/S's headquarters located?

Orphazyme A/S's main headquarters is located at DK. The company has employees across 3 continents, including EuropeNorth AmericaAfrica.

What is Orphazyme A/S's phone number?

You can contact Orphazyme A/S's main corporate office by phone at

+45-70-70-2****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Orphazyme A/S's stock symbol?

Orphazyme A/S is a publicly traded company; the company's stock symbol is ORPHY.

What is Orphazyme A/S's official website and social media links?

Orphazyme A/S's official website is orphazyme.com and has social profiles on LinkedIn.

What is Orphazyme A/S's SIC code NAICS code?

Orphazyme A/S's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Orphazyme A/S have currently?

As of December 2021, Orphazyme A/S has approximately 108 employees across 3 continents, including EuropeNorth AmericaAfrica. Key team members include Chief Commercial Officer And Us President: P. M.Head Of Global Product Strategy: A. H.Director - National Accounts: J. M.. Explore Orphazyme A/S's employee directory with LeadIQ.

What industry does Orphazyme A/S belong to?

Orphazyme A/S operates in the Biotechnology Research industry.

What technology does Orphazyme A/S use?

Orphazyme A/S's tech stack includes jQuery MigrateUnderscore.jsWebpackUbuntuAmazon Web ServicesPHPYoast SEOTwitter.

What is Orphazyme A/S's email format?

Orphazyme A/S's email format typically follows the pattern of . Find more Orphazyme A/S email formats with LeadIQ.

How much funding has Orphazyme A/S raised to date?

As of December 2021, Orphazyme A/S has raised $109M in funding. The last funding round occurred on Feb 07, 2020 for $109M.

When was Orphazyme A/S founded?

Orphazyme A/S was founded in 2009.

Orphazyme A/S

Biotechnology ResearchDenmark51-200 Employees

Orphazyme is a global biopharmaceutical company, headquartered in Denmark, with a rapidly growing presence in the United States. We are pioneering a new kind of treatment, applying our specialized expertise to bring innovative therapies to patients with neurodegenerative orphan diseases. With a late-stage drug pipeline, we are relentless in our commitment to advancing treatments and making a profound impact for those touched by these rare, serious diseases.

Today we are listed on Nasdaq Copenhagen (TICKER: ORPHA.CO) and Nasdaq U.S. (TICKER: ORPH), and are expanding our global presence with offices in Denmark, Switzerland, and our US headquarters in Chicago.

See our community guidelines: bit.ly/3uapRYr

Company Overview

Headquarters: DK
Phone number: ✕
Access Insights for Orphazyme A/S and Millions of Other Companies
Sign up for full access to Orphazyme A/S information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+45-70-70-2****
Website: orphazyme.com
SIC Code: 8733 - Noncommercial Research Organizations
Stock Symbol: ORPHY
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2009
Employees: 51-200

Media & News

Funding & Financials

$109M
Orphazyme A/S has raised a total of $109M of funding over 7 rounds. Their latest funding round was raised on Feb 07, 2020 in the amount of $109M.

Funding & Financials

$109M
Orphazyme A/S has raised a total of $109M of funding over 7 rounds. Their latest funding round was raised on Feb 07, 2020 in the amount of $109M.

Company Leadership

P. M.
Chief Commercial Officer And Us President
✕
Access Insights for Orphazyme A/S and Millions of Other Companies
Sign up for full access to Orphazyme A/S information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Orphazyme A/S and Millions of Other Companies
Sign up for full access to Orphazyme A/S information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. H.
Head Of Global Product Strategy
✕
Access Insights for Orphazyme A/S and Millions of Other Companies
Sign up for full access to Orphazyme A/S information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Orphazyme A/S and Millions of Other Companies
Sign up for full access to Orphazyme A/S information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. M.
Director - National Accounts
✕
Access Insights for Orphazyme A/S and Millions of Other Companies
Sign up for full access to Orphazyme A/S information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Orphazyme A/S and Millions of Other Companies
Sign up for full access to Orphazyme A/S information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
K. K. B.
Associate Medical Director
✕
Access Insights for Orphazyme A/S and Millions of Other Companies
Sign up for full access to Orphazyme A/S information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Orphazyme A/S and Millions of Other Companies
Sign up for full access to Orphazyme A/S information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
T. A.
Director, Us Medical Information Lead
✕
Access Insights for Orphazyme A/S and Millions of Other Companies
Sign up for full access to Orphazyme A/S information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Orphazyme A/S and Millions of Other Companies
Sign up for full access to Orphazyme A/S information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

T. D.
Executive Director, Payer Engagement
✕
Access Insights for Orphazyme A/S and Millions of Other Companies
Sign up for full access to Orphazyme A/S information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Orphazyme A/S and Millions of Other Companies
Sign up for full access to Orphazyme A/S information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. S. B.
Project Research Manager
✕
Access Insights for Orphazyme A/S and Millions of Other Companies
Sign up for full access to Orphazyme A/S information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Orphazyme A/S and Millions of Other Companies
Sign up for full access to Orphazyme A/S information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
C. B.
External Business Change Manager
✕
Access Insights for Orphazyme A/S and Millions of Other Companies
Sign up for full access to Orphazyme A/S information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Orphazyme A/S and Millions of Other Companies
Sign up for full access to Orphazyme A/S information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
V. G.
Us Human Resources Lead
✕
Access Insights for Orphazyme A/S and Millions of Other Companies
Sign up for full access to Orphazyme A/S information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Orphazyme A/S and Millions of Other Companies
Sign up for full access to Orphazyme A/S information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. M.
Senior Scientist
✕
Access Insights for Orphazyme A/S and Millions of Other Companies
Sign up for full access to Orphazyme A/S information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Orphazyme A/S and Millions of Other Companies
Sign up for full access to Orphazyme A/S information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to Orphazyme A/S

iTeos Therapeutics

Applied Biological Materials

Theradaptive

ANAVEON AG

AlloVir

Palleon Pharmaceuticals

MaaT Pharma

Orphazyme A/S Tech Stack

Media & News

Orphazyme Aps sold assets to Zevra Therapeutics Inc. in the amount of $12.8M on May 1st '22.

Orphazyme Aps went public on Sep 1st '20.

Orphazyme Aps sells assets to KemPharm, Inc. in the amount of $12.8M.

Orphazyme Aps partnered with KemPharm, Inc. on May 15th '22.

Christophe Bourdon left Orphazyme Aps as CEO on Jan 1st '22.

Orphazyme Aps hired Anders Vadsholt as CEO on Apr 1st '22.

Orphazyme Aps launches update to financial outlook for 2021.

Orphazyme A/S's Email Address Formats

Frequently Asked Questions

Where is Orphazyme A/S's headquarters located?

What is Orphazyme A/S's phone number?

What is Orphazyme A/S's stock symbol?

What is Orphazyme A/S's official website and social media links?

What is Orphazyme A/S's SIC code NAICS code?

How many employees does Orphazyme A/S have currently?

What industry does Orphazyme A/S belong to?

What technology does Orphazyme A/S use?

What is Orphazyme A/S's email format?

How much funding has Orphazyme A/S raised to date?

When was Orphazyme A/S founded?

Orphazyme A/S

Company Overview

Media & News

Orphazyme Aps sold assets to Zevra Therapeutics Inc. in the amount of $12.8M on May 1st '22.

Orphazyme Aps went public on Sep 1st '20.

Orphazyme Aps sells assets to KemPharm, Inc. in the amount of $12.8M.

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?